Who Is Green Roads? A Brand File on the Pharmacist-Formulated CBD Brand

A long-running, pharmacist-founded CBD brand with per-batch QR COAs and an independent lab test that actually passed — genuine strengths. The asterisks: a 2017 FDA warning letter, dismissed mislabeling suits, thin sourcing disclosure, and an ownership chain that's changed hands three times.

By The Kind Buds Desk · 11 min read · Updated 2026-06-29

C67/100

Kind Buds Brand Transparency Score

A pharmacist-founded CBD veteran with real lab transparency — per-batch QR COAs, full panels, and an independent test that passed label accuracy — offset by a 2017 FDA warning letter, dismissed mislabeling suits, thin sourcing disclosure, no third-party facility certification, and a thrice-changed ownership chain.

An opinion grade from our transparent 6-pillar methodology, built on publicly sourced facts.

Lab Testing & Safety18/25

Strong: every batch carries a QR code to a third-party COA, a public lab-sheets page, full contaminant panels, and — notably — an independent LeafReport lab test that found the product within tolerance and clean. The lab (reportedly Kaycha) is confirmed mainly via secondary sources, and there's no US Hemp Authority certification.

Manufacturing Transparency10/15

In-house via a named subsidiary (Clarity Labs) with a Florida state OTC-manufacturer permit and company-stated cGMP — but no third-party NSF/ISO facility certification, and it shouldn't be called 'FDA-approved.'

Sourcing & Ingredients9/15

Pharmacist-formulated, with full/broad-spectrum and isolate options and per-product ingredient lists — but the hemp source, farms, and extraction method aren't disclosed, and it's not certified organic.

Ownership & Funding11/15

The full ownership chain is publicly documented (founder → Valens → SNDL → Global Widget), and the founders are named — though current parent Global Widget is private and post-2023 leadership isn't clearly confirmed.

People & Operations9/15

A modest Florida operation (~50 employees by estimate) with named founders and a known Deerfield Beach HQ; current headcount and a Glassdoor read aren't clearly public.

Reputation & Record10/15

A pharmacist-formulated reputation and an independent lab pass — against a 2017 FDA warning letter (disease claims, resolved-era), dismissed mislabeling class actions, a fluctuating BBB rating, and mixed customer-service reviews.

Green Roads is one of the older names in CBD, and one of the few with a genuine clinical hook: it was co-founded in 2013 by Laura Baldwin Fuentes, a licensed compounding pharmacist, and built its brand on "pharmacist-formulated" products. It's widely stocked — oils, gummies, topicals, sleep and pet lines — and it does some real transparency work. We ran it through our six-pillar Brand Transparency Score and it lands at a C (67/100).

The strengths are concrete: per-batch QR-linked Certificates of Analysis, full contaminant panels, and — unusually — an independent lab test (by a third-party auditor) that actually passed on both potency and purity. The drags are equally concrete: a 2017 FDA warning letter (which we'll date and frame correctly, because it's often misreported), a set of dismissed mislabeling lawsuits, thin sourcing disclosure, no third-party facility certification, and an ownership chain that has changed hands three times since 2021. Here's the receipts-first reality.

The short version

  • Our grade: C (67/100). Real lab transparency and a pharmacist pedigree, with several honest asterisks.
  • Independently verified. Beyond its own per-batch QR COAs and full panels, a third-party auditor (LeafReport) lab-tested a Green Roads oil and found it within label tolerance, THC-free, and passing contaminant screens.
  • Pharmacist-founded. Co-founder and longtime CEO Laura Baldwin Fuentes is a licensed compounding pharmacist — the basis of its 'pharmacist-formulated' identity.
  • The FDA letter, dated correctly. Green Roads' FDA warning letter is from October 2017 (FDA only, no FTC) over disease claims — not 2019, and not to be conflated with the separate 2019 mislabeling lawsuits.
  • Owned, sold, sold again. Green Roads passed from its founders to The Valens Company (2021), then to SNDL, then to Global Widget LLC (2023) — all publicly documented, but a lot of turnover.
What the public record shows
Legal entityGreen Roads of Florida LLC
Founded2013, Florida
FoundersLaura Baldwin Fuentes (pharmacist) & Arby Barroso
HQDeerfield Beach, Florida
Current parentGlobal Widget LLC (since 2023)
ManufacturingIn-house (Clarity Labs); FL OTC permit; company-stated cGMP
Lab testingPer-batch QR COAs; full panel; independent LeafReport pass
Hemp sourceNot disclosed; not certified organic
FDA actionOct 2017 warning letter (disease claims; FDA only)
LawsuitsMislabeling class actions — dismissed, no liability

Green Roads at a glance — the verified facts

The short version

Green Roads is a credible, pharmacist-founded CBD brand that backs its testing with independent proof — and carries some real, mostly-old baggage. Its per-batch QR COAs, full panels, and a passing third-party lab test are exactly the kind of verifiable transparency our score rewards. But a 2017 FDA letter, dismissed mislabeling suits, undisclosed sourcing, no third-party facility certification, and three changes of ownership in three years keep it in the middle of the pack.

We'll be precise about the negatives — especially the FDA letter, which is frequently misdated — and credit the genuine strengths, including the independent lab verification that most brands can't point to.

Who's behind it? (A pharmacist — and three owners)

Green Roads is operated by Green Roads of Florida LLC, based in Deerfield Beach, Florida, and founded in 2013. Its defining feature is its co-founder and longtime CEO, Laura Baldwin Fuentes, a licensed compounding pharmacist whose formulations anchor the "pharmacist-formulated" brand identity; co-founder Arby Barroso is the public CBD-advocate face.

Ownership has turned over a lot. Green Roads is no longer founder-owned, and the chain is fully documented: it was acquired by Canada's The Valens Company in 2021 (~$40M plus an earnout), Valens was itself absorbed by SNDL Inc. in early 2023, and Green Roads was then sold to Global Widget LLC (the house behind Hemp Bombs and others) in mid-2023. That's three owners in about three years — public and traceable, which is good, but a lot of churn, and it means we can't firmly confirm the current (Global-Widget-era) leadership, so we don't assert it.

Lab testing — and an independent pass

This is Green Roads' strongest pillar, and it has something most brands don't: outside verification.

  • Per-batch QR COAs. Every batch carries a QR code linking to a third-party Certificate of Analysis, and there's a public lab-sheets page — easy to find.
  • Full panels. The COAs cover cannabinoid potency, THC, heavy metals, microbials, and pesticides — a complete contaminant screen.
  • An independent pass. The third-party auditor LeafReport, which buys and tests products itself, lab-tested a Green Roads full-spectrum oil and found it within label tolerance (~3% variance), THC-free, and passing all contaminant panels — a genuine, outside confirmation of label accuracy that we credit.

Two honest caveats: the specific testing lab (reportedly Kaycha, an ISO-17025 lab) is confirmed mainly through secondary sources rather than a prominent first-party statement, and Green Roads does not hold US Hemp Authority certification. But "QR COAs + full panel + an independent pass" is a real, verifiable foundation.

Manufacturing and sourcing

On manufacturing, Green Roads makes products in-house through a named subsidiary, Clarity Labs LLC, which holds a Florida state OTC-manufacturer permit and operates to company-stated cGMP practices. That's more specific than most — but two precision points: a state OTC permit is not the same as "FDA-approved manufacturing," and we found no third-party NSF or ISO certification for the facility (unlike CBDistillery's or cbdMD's NSF registration). On sourcing, the pharmacist-formulation story is the headline, with full/broad-spectrum and isolate options and per-product ingredient lists — but the hemp source, farms, and extraction method aren't disclosed, and it isn't certified organic. Solid where it's documented; quiet on provenance.

The record: an old FDA letter, dismissed suits, mixed reviews

Green Roads' record has real items, and the most-misreported one needs precise dating:

  • The 2017 FDA warning letter. The FDA warned the company in October 2017 — addressed to Laura Fuentes / Greenroads Health — over marketing CBD products with disease/drug claims (cancer, Alzheimer's, etc.) and adding CBD to food. Two corrections we insist on: it was 2017, not 2019, and it was issued by the FDA alone (no FTC). The "2019" you may see elsewhere conflates this letter with the separate lawsuits below. The company subsequently removed the disease claims.
  • Dismissed mislabeling lawsuits. Putative class actions filed around 2019 alleged Green Roads misrepresented CBD content; the litigation was stayed pending FDA rulemaking, class certification was denied, and the suits were voluntarily dismissed without prejudiceno settlement and no finding of liability. Allegations, unresolved on the merits.
  • Mixed consumer signals. Its BBB rating is not accredited and has fluctuated across snapshots (on low complaint volume), and its Trustpilot is mixed — praise for products, recurring complaints about customer service and shipping.

On the other side of the ledger: the independent LeafReport lab pass, the long-standing pharmacist-formulated reputation, and broad retail distribution are real positives.

The bottom line

In our view, Green Roads is a credible mid-tier CBD brand whose lab transparency outruns its sourcing transparency. It gives you per-batch QR COAs, full panels, and the rare reassurance of an independent lab test that passed — the substance our score rewards. But it's weighed down by a 2017 FDA letter, dismissed-but-real mislabeling litigation, a facility that's only state-permitted (not third-party certified), undisclosed sourcing, and an ownership chain that's turned over three times. That mix is a textbook C: genuinely useful, verifiably tested, and short of the certified, fully-disclosed top tier.

If you buy Green Roads, scan the QR for your batch's full-panel COA (and take comfort that an outside lab has vouched for label accuracy), but don't expect named farms, organic certification, or third-party facility credentials. There are CBD brands graded higher here (CBDistillery, Charlotte's Web) that add those. A C (67/100) — pharmacist-formulated, independently tested, and honestly imperfect. The full methodology shows every point; named-lab first-party disclosure, a facility certification, and sourcing transparency would lift it (see the notice below).

Questions, answered

Is Green Roads legit?

Yes — it's an established, pharmacist-founded CBD brand (since 2013) with real transparency credentials: per-batch QR-linked Certificates of Analysis, full contaminant panels, and — notably — an independent third-party lab test (by LeafReport) that found a Green Roads oil within label tolerance, THC-free, and passing contaminant screens. We grade it a C (67/100). The drags: a 2017 FDA warning letter over disease claims (resolved-era), dismissed mislabeling lawsuits, thin sourcing disclosure, no third-party facility certification, and an ownership chain that changed hands three times since 2021. Solid and verifiably tested, but short of the certified top tier.

Who owns Green Roads?

Green Roads (legally Green Roads of Florida LLC, Deerfield Beach, FL) was founded in 2013 by Laura Baldwin Fuentes — a licensed compounding pharmacist — and Arby Barroso. It's no longer founder-owned: it was acquired by The Valens Company (Canada) in 2021, Valens was then absorbed by SNDL Inc. in early 2023, and Green Roads was sold to Global Widget LLC (the house behind Hemp Bombs and other brands) in mid-2023, which is the current parent. That chain is publicly documented, but it's a lot of turnover in a short time, and we couldn't firmly confirm the current Global-Widget-era leadership, so we don't assert it.

Are Green Roads lab tests trustworthy?

They're among its strongest features, and unusually, they have outside backing. Green Roads puts a QR code on each batch linking to a third-party Certificate of Analysis, maintains a public lab-sheets page, and its COAs cover a full panel (potency, THC, heavy metals, microbials, pesticides). On top of that, the independent auditor LeafReport lab-tested a Green Roads oil itself and found it within label tolerance, THC-free, and passing all contaminant screens — a real, external verification most brands can't point to. The caveats: the specific lab (reportedly Kaycha) is confirmed mainly via secondary sources, and Green Roads doesn't hold US Hemp Authority certification. Scan your batch's QR to confirm.

Did Green Roads get an FDA warning letter?

Yes, but the details are frequently reported wrong. Green Roads' FDA warning letter is dated October 2017 — not 2019 — and was issued by the FDA alone (no FTC), addressed to co-founder Laura Fuentes / Greenroads Health, over marketing CBD products with disease/drug claims (cancer, Alzheimer's, etc.) and adding CBD to food. The company subsequently removed those claims. The '2019' you may see elsewhere conflates this 2017 FDA letter with separate consumer mislabeling lawsuits filed around 2019 — those are a different event, and they were dismissed without a finding of liability. So: a real but old, resolved-era regulatory letter, which we weight accordingly.

What were the Green Roads lawsuits about?

Around 2019, putative class actions alleged that Green Roads misrepresented the CBD content of its products on labels and packaging. It's important to be precise about how they ended: the litigation was stayed pending FDA rulemaking on CBD, an attempt to certify a class was denied, and the suits were voluntarily dismissed without prejudice — meaning there was no settlement and no finding of liability against Green Roads. They're unproven allegations that didn't reach an adverse judgment. Notably, an independent auditor (LeafReport) later lab-tested a Green Roads product and found its potency within tolerance, which cuts against the mislabeling theory for that product.

How did you research this, and is it fair to Green Roads?

Every claim is from a public source — Green Roads' own site and lab-sheets page, the FDA warning-letter record, court dockets and legal trade press, the acquisition announcements (Valens/SNDL/Global Widget), an independent LeafReport lab test, and the BBB/Trustpilot. We credited the genuine strengths (per-batch QR COAs, full panels, an independent lab pass, pharmacist formulation) and were careful with the negatives: we corrected the FDA letter to its actual 2017 date and FDA-only status, framed the lawsuits as dismissed allegations with no liability, declined to call its state-permitted facility 'FDA-approved,' and noted its BBB rating fluctuates. The C reflects strong lab transparency held back by sourcing gaps and an old regulatory/legal record. If Green Roads names its lab first-party, certifies its facility, and discloses sourcing, we'll update the file — see the notice at the foot of this page.